We include products we think are useful. If you buy through the links on this page, we may receive a commission.
- Is there a generic version of Saxenda available in the United States? - April 3, 2026
- Does an electric toothbrush help with gingivitis? - April 2, 2026
- How much does omeprazole cost in Spain? - April 1, 2026
Yes. In the United States there is already a generic version of Saxenda. The FDA approved the first liraglutide injection referencing Saxenda on August 27, 2025, and Teva announced its launch the following day.
What is the generic name for Saxenda?
The name that appears in the official documentation of the generic is liraglutide injection, and MedlinePlus refers the brand name Saxenda to the liraglutide information sheet while the FDA uses that same name in its record of first approvals.
The relationship between brand and generic is clearly seen in official sources, because Saxenda is listed as a brand associated with liraglutide and the product approved as a generic is described as liraglutide injection.
Since when has the generic version of Saxenda been available in the US?
The key regulatory date is August 27, 2025, when the FDA included the approval as ANDA 214568 on its list of first generic approvals for chronic weight management.
The FDA's own annual GDUFA report again included liraglutide injection for Saxenda among the first significant generics for fiscal year 2025, with the indication summarized as chronic weight management.
Weight control
Why it might fit
- Weight and body composition in one device.
- Helps to better interpret whether weight gain is due to body fat or muscle mass.
- Includes Bluetooth to check historical progress in the app.
What to keep in mind
- Costs more than a normal scale.
What changes and what doesn't change with a generic version of Saxenda?
The existence of a generic does not change the essential regulatory basis of the product, because the FDA requires that an approved generic have the same active ingredient, the same pharmaceutical form, the same route of administration, and the same intended use.
The agency also explains that FDA-approved generics provide the same clinical benefits and risks as the brand name, although there may be minor differences in some inactive ingredients or permitted labeling details.
Is it still a prescription medication?
It remains a prescription drug, because the liraglutide injection medication guide describes it as an injectable prescription medicine for obese or overweight people with weight-related problems.
Both the Saxenda and liraglutide injection product information sheets maintain the reference to a low-calorie diet and physical activity as part of the authorized use, not as a separate piece of information from the treatment.
Where does the generic name for Saxenda appear?
Both information sheets also indicate that it is not recommended to use it together with other products containing liraglutide or with another GLP-1 receptor agonist, so the generic version does not change that limitation of use.
To quickly check, the FDA's list of first generic approvals shows the approval, and DailyMed compiles the medication guide and official product information.
In official US records, the current answer is clear: the generic version of Saxenda exists, is approved, and is identified as liraglutide injection, not solely under the Saxenda brand name.
This content is for informational purposes only and is not a substitute for medical advice. Before starting or changing any treatment, consult a healthcare professional.
